Header Logo

Connection

Peter Heydemann to Oxadiazoles

Back to Details
This is a "connection" page, showing publications Peter Heydemann has written about Oxadiazoles.
Peter Heydemann
Connection Strength
0.155
Oxadiazoles
  1. Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017 09 23; 390(10101):1489-1498.
    View in: PubMed
    Score: 0.155
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.